Paolo Faccendini
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Predictors of linkage to prevention services after HIV post-exposure prophylaxis (PEP): A single-centre retrospective analysis, years 2019-2024.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 23, 2025
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy).
Journal: Human vaccines & immunotherapeutics
Published: November 06, 2025
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: October 03, 2025
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route.
Journal: Vaccines
Published: November 06, 2024
Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital.
Journal: Antibiotics (Basel, Switzerland)
Published: November 02, 2024
Tecovirimat concentrations and viral suppression in seminal fluid from patients with mpox.
Journal: The Lancet. Infectious diseases
Published: March 09, 2023
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.
Journal: Journal of medical virology
Published: February 23, 2023
Pharmacokinetics of tecovirimat in subjects with Mpox.
Journal: International journal of antimicrobial agents
Published: January 30, 2023
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital.
Journal: The Journal of infection
Published: October 26, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026